Fig. 2
From: BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
The relationship between BTG1 and various clinical pathological parameters and prognosis in EC. a Expression of BTG1 in UCEC based on Sample types in UALCAN. b Expression of BTG1 in UCEC based on individual cancer stages in UALCAN. c Expression of BTG1 in UCEC based on patient’s weight in UALCAN. d Expression of BTG1 in UCEC based on patient’s age in UALCAN. e Expression of BTG1 in UCEC based on Histological subtypes in UALCAN. f Expression of BTG1 in UCEC based on TP53 mutation status in UALCAN. g The effect of BTG1 on the prognosis of endometrial cancer in KM plotter online analysis